$0.0959
+0 (+0%)
At Close: Apr 28, 2026
Applied Therapeutics, Inc. Announces Upsizing and Pricing of Public Offering of 2,741,489 Shares of Common Stock
02:28am, Friday, 24'th Jan 2020
Applied Therapeutics, Inc. (APLT) (the “Company”), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of h
The Daily Biotech Pulse: Johnson & Johnson Earnings, FDA Nod For Horizon Therapeutics, Slew Of Secondary Offerings
01:25pm, Wednesday, 22'nd Jan 2020
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Jan. 21) Abbott Laboratories (NYSE: ABT ) Apellis Pharmaceu
Applied Therapeutics, Inc. Announces Offering of 1,750,000 Shares of Common Stock
09:16pm, Tuesday, 21'st Jan 2020
Applied Therapeutics, Inc. (APLT) (the “Company”), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of h
The Daily Biotech Pulse: Osmotica Soars On Insider Buys, Ultragenyx's Partnered Rare Disease Drug Moves Into Clinics
12:22pm, Thursday, 16'th Jan 2020
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Jan. 15) 10X Genomics Inc (NASDAQ: TXG ) Aimmune Therapeuti
The Daily Biotech Pulse: Nektar Withdraws Opioid Pain Drug NDA, Galapagos Takes Stake In Fibrocor, Integra Lifesciences Lowers Q4 Guidance
01:22pm, Wednesday, 15'th Jan 2020
The following is a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs on Jan. 14.) Adaptimmune Therapeutics PLC – ADR (
Applied Therapeutics Shares March Higher, Can It Continue?
01:27pm, Tuesday, 14'th Jan 2020
As of late, it has definitely been a great time to be an investor Applied Therapeutics.
Applied Therapeutics Up on Positive Galactosemia Study Data
09:47pm, Thursday, 09'th Jan 2020
Applied Therapeutics (APLT) soars on positive top-line results from the mid-stage study in adult Galactosemia patients on pipeline candidate, AT-007.
How Microsoft and DAA use AI to innovate the airport passenger's journey
06:00am, Thursday, 21'st Feb 2019
AI is allowing Microsoft and the DAA meet demand and improve services at our airports
Sign In
Buy APLT